Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121867853 | 12186785 | 3 | F | 20110827 | 20160712 | 20160317 | 20160720 | EXP | US-PFIZER INC-2016148529 | PFIZER | 70.00 | YR | F | Y | 56.70000 | KG | 20160720 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121867853 | 12186785 | 1 | PS | LYRICA | PREGABALIN | 1 | UNK | 21446 | |||||||||||
| 121867853 | 12186785 | 2 | SS | LYRICA | PREGABALIN | 1 | UNK | 21446 | |||||||||||
| 121867853 | 12186785 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | 600 UNK, UNK | 20235 | 600 | MG | TID | ||||||||
| 121867853 | 12186785 | 4 | SS | GABAPENTIN. | GABAPENTIN | 1 | 600 UNK, 3X/DAY | 20235 | 600 | MG | TID | ||||||||
| 121867853 | 12186785 | 5 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
| 121867853 | 12186785 | 6 | C | MELOXICAM. | MELOXICAM | 1 | UNK | 0 | |||||||||||
| 121867853 | 12186785 | 7 | C | PRAMIPEXOLE. | PRAMIPEXOLE | 1 | UNK | 0 | |||||||||||
| 121867853 | 12186785 | 8 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 121867853 | 12186785 | 9 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | UNK | 0 | |||||||||||
| 121867853 | 12186785 | 10 | C | LOSARTAN / HIDROCLOROTIAZIDA | HYDROCHLOROTHIAZIDELOSARTAN | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 121867853 | 12186785 | 11 | C | LORAZEPAM. | LORAZEPAM | 1 | 1 MG, UNK | 0 | 1 | MG | |||||||||
| 121867853 | 12186785 | 12 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 121867853 | 12186785 | 13 | C | OXYCODONE WITH APAP | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | UNK (OXYCODONR-5 MG /APAP-325 MG) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121867853 | 12186785 | 1 | Fibromyalgia |
| 121867853 | 12186785 | 3 | Fibromyalgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121867853 | 12186785 | HO |
| 121867853 | 12186785 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121867853 | 12186785 | Activities of daily living impaired | |
| 121867853 | 12186785 | Fall | |
| 121867853 | 12186785 | Gait disturbance | |
| 121867853 | 12186785 | Limb discomfort | |
| 121867853 | 12186785 | Neuropathy peripheral | |
| 121867853 | 12186785 | Product use issue | |
| 121867853 | 12186785 | Spinal column stenosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121867853 | 12186785 | 1 | 2012 | 0 | ||
| 121867853 | 12186785 | 2 | 2015 | 0 | ||
| 121867853 | 12186785 | 3 | 1999 | 0 | ||
| 121867853 | 12186785 | 4 | 2012 | 0 |